Abstract
Motor neuron diseases (MNDs) are progressive neurodegenerative disorders affecting spinal and bulbar nerves. Of this class of diseases, amyotrophic lateral sclerosis (ALS) is the most common. Other MNDs differ in age of onset, distribution of motor neuron involvement, and disease severity. Most occur sporadically and have no clear cause, while a minority are inherited. All share an unrelenting course without known cure and commonly impair communication, deglutition, and respiration. They universally create significant impact to patient’s quality of life, nutritional status, and longevity. Treatments focus on managing symptoms and preventing adverse sequelae related to neurologic deficits.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vesey S. The challenges of dysphagia in treating motor neurone disease. Br J Community Nurs. 2017;22(Suppl 7):S17–21.
Luchesi KF, Kitamua S, Mourão LF. Amyotrophic lateral sclerosis survival analysis: swallowing and non-oral feeding. Neuro Rehabilitation. 2014;35(3):535–42.
Nakamori M, Hosomi N, Takaki S, Oda M, Hiraoka A, Yoshikawa M, et al. Tongue thickness evaluation using ultrasonography can predict swallowing function in amyotrophic lateral sclerosis patients. Clin Neurophysiol. 2016;127(2):1669–74.
Armon C. An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology. 2003;22(4):217–28.
National Institute of Neurological Disorders and Stroke. Motor Neuron Diseases Information Page. Date last modified: 27 Mar 2019. https://www.ninds.nih.gov/Disorders/All-Disorders/Motor-Neuron-Diseases-Information-Page. Accessed 19 Jun 2019.
Rowland LP. How amyotrophic lateral sclerosis got its name: the clinical-pathologic genius of Jean-Martin Charcot. Arch Neurol. 2001;58(3):512–5.
Riva N, Agosta F, Lunetta C, et al. Neurological update: recent advances in amyotrophic lateral sclerosis. Neurology. 2016;263:1241–54.
Murono S, Hamaguchi T, Yoshida H, Nakanishi Y, Tsuji A, Endo K, et al. Evaluation of dysphagia at the initial diagnosis of amyotrophic lateral sclerosis. Auris Nasus Larynx. 2015;42(3):213–7.
Finsterer J, Soraru G. Onset manifestations of spinal and bulbar muscular atrophy (Kennedy’s Disease). J Mol Neurosci. 2016;58(3):321–9.
MacLean HE, Warne GL, Zajac JD. Spinal and bulbar muscular atrophy: androgen receptor dysfunction caused by a trinucleotide repeat expansion. J Neurol Sci. 1996;135(2):149–57.
Fink JK. Progressive spastic paraparesis: hereditary spastic paraplegia and its relation to primary and amyotrophic lateral sclerosis. Semin Neurol. 2001;21(2):199–207.
Stevanin G, Azzedine H, Denora P, Boukhris A, Tazir M, Lossos A, et al. Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain. 2008;131(Pt 3):772–84.
Fink JK. Hereditary spastic paraplegia. Curr Neurol Neurosci Rep. 2006;6(1):65–76.
Mannan AU, Krawen P, Sauter SM, Boehm J, Chronowska A, Paulus W, et al. ZFYVE27 (SPG33), a novel spastin-binding protein, is mutated in hereditary spastic paraplegia. Am J Hum Genet. 2006;79(2):351–7.
Rubin AD, Griffin GR, Hogikyan ND, Feldman EL. A new member of the multidisciplinary ALS team: the otolaryngologist. Amyotroph Lateral Scler. 2012;13(2):229–32.
Beghi E, Chiò A, Couratier P, Esteban J, Hardiman O, Logroscino G, et al. The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotroph Lateral Scler. 2011;12(1):1–10.
Chen A, Garrett CG. Otolaryngologic presentations of amyotrophic lateralsclerosis. Otolaryngol Head Neck Surg. 2005;132(3):500–4.
Talbott EO, Malek AM, Lacomis D. The epidemiology of amyotrophic lateral sclerosis. Handb Clin Neurol. 2016;138:225–38.
Almer G, Vukosavic S, Romero N, Przedborski S. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem. 1999;72(6):2415–25.
Wiedemann FR, Winkler K, Kuznetsov AV, Bartels C, Vielhaber S, Feistner H, et al. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci. 1998;156(1):65–72.
D’Amico E, Pasmantier M, Lee YW, Weimer L, Mitsumoto H. Clinical evolution of pure upper motor neuron disease/dysfunction (PUMMD). Muscle Nerve. 2013;47(1):28–32.
Valadi N. Evaluation and management of amyotrophic lateral sclerosis. Prim Care. 2015;42(2):177–87.
Mayberry JF, Atkinson M. Swallowing problems in patients with motor neuron disease. J Clin Gastroenterol. 1986;8(3 Pt 1):233–4.
Stambler N, Charatan M, Cedarbaum JM. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology. 1998;50(1):66–72.
Motor Neuron Disease Association, Northampton, United Kingdom. Cognitive change and frontotemporal dementia. Updated Jun 2019. http://bit.ly/2rJc0w4. Accessed 19 Jun 2019.
Cohen SM, Elackattu A, Noordzij JP, Walsh MJ, Langmore SE. Palliative treatment of dysphonia and dysarthria. Otolaryngol Clin N Am. 2009;42(1):107–21, x.
Kühnlein P, Gdynia HJ, Sperfeld AD, Lindner-Pfleghar B, Ludolph AC, Prosiegel M, et al. Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis. Nat Clin Pract Neurol. 2008;4(7):366–74.
Leighton SE, Burton MJ, Lund WS, Cochrane GM. Swallowing in motor neurone disease. J R Soc Med. 1994;87(12):801–5.
van den Engel-Hoek L, Erasmus CE, van Bruggen HW, de Swart BJ, Sie LT, Steenks MH, et al. Dysphagia in spinal muscular atrophy type II: more than a bulbar problem? Neurology. 2009;73(21):1787–91.
R W, M I, M H, J S. M H. primary lateral sclerosis. Neuropathology. 1997;17(3):220–4.
Szacka K, Potulska-Chromik A, Fronczewska-Wieniawska K, Spychała A, Kròlicki L, Kuźma-Kozakiewicz M. Scintigraphic evaluation of mild to moderate dysphagia in motor neuron disease. Clin Nucl Med. 2016;41(4):e175–80.
Cerero Lapiedra R, Moreno López LA, Esparza Gómez GC. Progressive bulbar palsy: a case report diagnosed by lingual symptoms. J Oral Pathol Med. 2002;31(5):277–9.
Amin MR, Harris D, Cassel SG, Grimes E, Heiman-Patterson T. Sensory testing in the assessment of laryngeal sensation in patients with amyotrophic lateral sclerosis. Ann Otol Rhinol Laryngol. 2006;115(7):528–34.
Corcia P, Pradat PF, Salachas F, Bruneteau G, Forestier N, Seilhean D, et al. Causes of death in a post-mortem series of ALS patients. Amyotroph Lateral Scler. 2008;9(1):59–62.
Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169(1–2):13–21.
Brandão RKC, de Carvalho GGP, Silva RR, Dias DLS, Mendes FBL, Lins TOJD, et al. Correlation between production performance and feeding behavior of steers on pasture during the rainy-dry transition period. Trop Anim Health Prod. 2018;50(1):105–11.
Tabor L, Gaziano J, Watts S, Robison R, Plowman EK. Defining swallowing-related quality of life profiles in individuals with amyotrophic lateral sclerosis. Dysphagia. 2016;31(3):376–82.
Waito AA, Valenzano TJ, Peladeau-Pigeon M, Steele CM. Trends in research literature describing dysphagia in motor neuron diseases (MND): a scoping review. Dysphagia. 2017;32(6):734–47.
Banno H, Katsuno M, Suzuki K, Tanaka S, Suga N, Hashizume A, et al. Swallowing markers in spinal and bulbar muscular atrophy. Ann Clin Transl Neurol. 2017;4(8):534–43.
Fattori B, Siciliano G, Mancini V, Bastiani L, Bongioanni P, Caldarazzo Ienco E, et al. Dysphagia in amyotrophic lateral sclerosis: relationships between disease progression and fiberoptic endoscopic evaluation of swallowing. Auris Nasus Larynx. 2017;44(3):306–12.
Plowman EK, Watts SA, Robison R, Tabor L, Dion C, Gaziano J, et al. Voluntary cough airflow differentiates safe versus unsafe swallowing in amyotrophic lateral sclerosis. Dysphagia. 2016;31(3):383–90.
Barber C. Management of bulbar symptoms in motor neurone disease: a community speech and language therapist perspective. Br J Neurosci Nursing. 2015;11(1):41–6.
Beukelman DR, Fager S, Ball L, Dietz A. AAC for adults with acquired neurological conditions: a review. Augment Altern Commun. 2007;23(3):230–42.
Plowman EK, Watts SA, Tabor L, Robison R, Gaziano J, Domer AS, et al. Impact of expiratory strength training in amyotrophic lateral sclerosis. Muscle Nerve. 2016;54(1):48–53.
Kübler A, Nijboer F, Mellinger J, Vaughan TM, Pawelzik H, Schalk G, et al. Patients with ALS can use sensorimotor rhythms to operate a brain-computer interface. Neurology. 2005;64(10):1775–7.
Group PS. Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study. Lancet Neurol. 2015;14(7):702–9.
Chiò A, Finocchiaro E, Meineri P, Bottacchi E, Schiffer D. Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS. ALS Percutaneous Endoscopic Gastrostomy Study Group. Neurology. 1999;53(5):1123–5.
Mitsumoto H, Davidson M, Moore D, Gad N, Brandis M, Ringel S, et al. Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4(3):177–85.
Katzberg HD, Benatar M. Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2011;1:CD004030.
Chhetri SK, Bradley BF, Majeed T, Lea RW. Enteral feeding in motor neurone disease: Patients’ perspectives and impact on quality of life. Palliat Med. 2017;31(7):676–7.
Niedermeyer S, Murn M, Choi PJ. Respiratory failure in amyotrophic lateral sclerosis. Chest. 2019;155(2):401–8.
Vianello A, Arcaro G, Palmieri A, Ermani M, Braccioni F, Gallan F, et al. Survival and quality of life after tracheostomy for acute respiratory failure in patients with amyotrophic lateral sclerosis. J Crit Care. 2011;26(3):329.e7–14.
Garvey CM, Boylan KB, Salassa JR, Kennelly KD. Total laryngectomy in patients with advanced bulbar symptoms of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10(5–6):470–5.
Geevasinga N, Menon P, Scherman DB, Simon N, Yiannikas C, Henderson RD, et al. Diagnostic criteria in amyotrophic lateral sclerosis: a multicenter prospective study. Neurology. 2016;87(7):684–90.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kuhn, M.A., Williams, L.M. (2020). Amyotrophic Lateral Sclerosis and Motor Neuron Disease. In: Weissbrod, P., Francis, D. (eds) Neurologic and Neurodegenerative Diseases of the Larynx. Springer, Cham. https://doi.org/10.1007/978-3-030-28852-5_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-28852-5_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-28851-8
Online ISBN: 978-3-030-28852-5
eBook Packages: MedicineMedicine (R0)